Terms: = Leukemia AND CTLA4, ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12 AND Clinical Outcome
15 results:
1. Somatic mutation-associated risk index based on lncRNA expression for predicting prognosis in acute myeloid leukemia.
Xu Q; Guo T
Hematology; 2022 Dec; 27(1):659-671. PubMed ID: 35666642
[No Abstract] [Full Text] [Related]
2. TIM-3 levels correlate with enhanced NK cell cytotoxicity and improved clinical outcome in AML patients.
Rakova J; Truxova I; Holicek P; Salek C; Hensler M; Kasikova L; Pasulka J; Holubova M; Kovar M; Lysak D; Kline JP; Racil Z; Galluzzi L; Spisek R; Fucikova J
Oncoimmunology; 2021 Mar; 10(1):1889822. PubMed ID: 33758676
[TBL] [Abstract] [Full Text] [Related]
3. [Donor chimerism and minimal residual disease monitoring in leukemia patients after allo-HSCT].
Bogdanov KV; Motorin DV; Nikulina TS; Pisotskaya OS; Babenetskaya DV; Mirolyubova YV; Volkova OY; Zaritskiy AY
Biomed Khim; 2017 Nov; 63(6):570-581. PubMed ID: 29251621
[TBL] [Abstract] [Full Text] [Related]
4. Role of regulatory T cells in acute myeloid leukemia patients undergoing relapse-preventive immunotherapy.
Sander FE; Nilsson M; Rydström A; Aurelius J; Riise RE; Movitz C; Bernson E; Kiffin R; Ståhlberg A; Brune M; Foà R; Hellstrand K; Thorén FB; Martner A
Cancer Immunol Immunother; 2017 Nov; 66(11):1473-1484. PubMed ID: 28721449
[TBL] [Abstract] [Full Text] [Related]
5. Improving therapeutic activity of anti-CD20 antibody therapy through immunomodulation in lymphoid malignancies.
Lipowska-Bhalla G; Fagnano E; Illidge TM; Cheadle EJ
Leuk Lymphoma; 2016; 57(6):1269-80. PubMed ID: 27050042
[TBL] [Abstract] [Full Text] [Related]
6. Chronic lymphocytic leukemia: a clinical review including Korean cohorts.
Jeon YW; Cho SG
Korean J Intern Med; 2016 May; 31(3):433-43. PubMed ID: 27044858
[TBL] [Abstract] [Full Text] [Related]
7. Patients with chronic lymphocytic leukaemia (CLL) differ in the pattern of ctla-4 expression on CLL cells: the possible implications for immunotherapy with ctla-4 blocking antibody.
Ciszak L; Frydecka I; Wolowiec D; Szteblich A; Kosmaczewska A
Tumour Biol; 2016 Mar; 37(3):4143-57. PubMed ID: 26490985
[TBL] [Abstract] [Full Text] [Related]
8. [Increased risk of severe acute graft-versus-host disease in low body mass index patients undergoing haploidentical allogeneic stem cell transplantation].
Chen Y; Xu L; Liu D; Liu K; Chen H; Zhang X; Wang F; Wang J; Wang Y; Han W; Chen Y; Yan C; Zhao T; Huang X
Zhonghua Nei Ke Za Zhi; 2014 Sep; 53(9):710-4. PubMed ID: 25511404
[TBL] [Abstract] [Full Text] [Related]
9. Primary plasma cell leukemia: clinical and laboratory presentation, gene-expression profiling and clinical outcome with Total Therapy protocols.
Usmani SZ; Nair B; Qu P; Hansen E; Zhang Q; Petty N; Waheed S; Shaughnessy JD; Alsayed Y; Heuck CJ; van Rhee F; Milner T; Hoering A; Szymonifka J; Sexton R; Sawyer J; Singh Z; Crowley J; Barlogie B
Leukemia; 2012 Nov; 26(11):2398-405. PubMed ID: 22508408
[TBL] [Abstract] [Full Text] [Related]
10. Donor ctla-4 genotype influences clinical outcome after T cell-depleted allogeneic hematopoietic stem cell transplantation from HLA-identical sibling donors.
Bosch-Vizcaya A; Pérez-García A; Brunet S; Solano C; Buño I; Guillem V; Martínez-Laperche C; Sanz G; Barrenetxea C; Martínez C; Tuset E; Lloveras N; Coll R; Guardia R; González Y; Roncero JM; Bustins A; Gardella S; Fernández C; Buch J; Gallardo D;
Biol Blood Marrow Transplant; 2012 Jan; 18(1):100-5. PubMed ID: 21703972
[TBL] [Abstract] [Full Text] [Related]
11. High expression of cathepsin D in non-Hodgkin's lymphomas negatively impacts on clinical outcome.
Nicotra G; Manfroi F; Follo C; Castino R; Fusco N; Peracchio C; Kerim S; Valente G; Isidoro C
Dis Markers; 2010; 28(3):167-83. PubMed ID: 20534902
[TBL] [Abstract] [Full Text] [Related]
12. [Current and new therapeutic strategies in acute myeloid leukemia].
Naito K; Ohnishi K
Gan To Kagaku Ryoho; 2005 Mar; 32(3):292-6. PubMed ID: 15791811
[TBL] [Abstract] [Full Text] [Related]
13. [clinical and laboratory studies on childhood acute leukemia with 11q23 abnormalities].
He YX; Xue YQ; He J; Zhang XL; Ji ZH; Huang YP; Zhu XM; He HL; Chai YH; Zhu LL
Zhonghua Xue Ye Xue Za Zhi; 2003 Jul; 24(7):358-61. PubMed ID: 12941190
[TBL] [Abstract] [Full Text] [Related]
14. [Allogeneic peripheral blood stem cell transplantation for treatment of leukemia].
Zhu K; Xu Y; Wu D; Xu X; Huang L
Zhonghua Nei Ke Za Zhi; 2001 Feb; 40(2):117-9. PubMed ID: 11798567
[TBL] [Abstract] [Full Text] [Related]
15. Immunophenotype of blast cells in acute myeloid leukemia may be a useful predictive factor for outcome.
Tucker J; Dorey E; Gregory WM; Simpson AP; Amess JA; Lister TA; Horton MA
Hematol Oncol; 1990; 8(1):47-58. PubMed ID: 2404842
[TBL] [Abstract] [Full Text] [Related]
